FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2019/07/020000 [Registered on: 02/07/2019] Trial Registered Prospectively
Last Modified On: 21/11/2019
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Comparative Study On Role Of Jalaukavcharana And Yashtyadi Lepa In Hordeolum 
Scientific Title of Study   A Comparative Clinical Study On Role Of Jalaukavcharana And Yashtyadi Lepa In Anjananamika With Special Reference To Hordeolum 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Prof Gunjan Sharma 
Designation  Professor and HOD 
Affiliation  Rishikul Campus UAU Haridwar 
Address  room no. 5 P.G. Department of Shalakya Tantra Rishikul Campus UAU Haridwar

Hardwar
UTTARANCHAL
249401
India 
Phone  8218428029  
Fax    
Email  gunjan06purity@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Prof Gunjan Sharma 
Designation  Professor and HOD 
Affiliation  Rishikul Campus UAU Haridwar 
Address  Room no. 5 P.G. Department of Shalakya Tantra Rishikul Campus UAU Haridwar

Hardwar
UTTARANCHAL
249401
India 
Phone  8218428029  
Fax    
Email  gunjan06purity@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Prof Gunjan Sharma 
Designation  Professor and HOD 
Affiliation  Rishikul Campus UAU Haridwar 
Address  Room No.5 P.G. Department of Shalakya Tantra Rishikul Campus UAU Haridwar

Hardwar
UTTARANCHAL
249401
India 
Phone  8218428029  
Fax    
Email  gunjan06purity@gmail.com  
 
Source of Monetary or Material Support  
Rishikul Campus UAU Haridwar 
 
Primary Sponsor  
Name  Rishikul Campus 
Address  Rishikul Campus UAU Haridwar 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Ranjana Negi  Rishikul Campus UAU Haridwar  Room no.5 P.G. Department of Shalakya Tantra Rishikul Campus UAU Haridwar
Hardwar
UTTARANCHAL 
7060187856

rnranjanasmart181@gmail.com 
 
Details of Ethics Committee
Modification(s)  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Comittee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: H000||Hordeolum (externum) (internum) ofeyelid,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Jalaukavcharana followed by Seka  Jalaukavcharana foolowed by seka will be performed for 5 days on alternate days i.e. 3 sittings will be done on 1st,3rd and 5th day.in between only Seka with Yashtyadi Kwatha will be done i.e. on 2nd and 4th day  
Comparator Agent  Vidalaka karma with Yashtyadi Lepa followed by Seka   Vidalaka with Yashtyadi Lepa will be done followed by Yashtyadi Kwatha Seka for 5 days  
 
Inclusion Criteria  
Age From  10.00 Year(s)
Age To  50.00 Year(s)
Gender  Both 
Details  patients having signs and symptoms of Anjananamika and External and Internal Hordeolum 
 
ExclusionCriteria 
Details   
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To assess the effect of therapy, objectively all signs and symptoms were given scoring depending upon their severity:
1-Cured:91-100% relief in signs and symptoms
2-Markedly improvement:76-90% relief in signs and symptoms
3-Moderately improvement:51-75% relief in signs and symptoms
4-Mild improvement:26-50% relief in signs and symptoms
5-Unchanged/no improvement:less than or equal to 25% relief in signs and symptoms 
assessment will be done on 1st day ,3rd day and 5th day after trial. overall assessment after 5 days of trial 
 
Secondary Outcome  
Outcome  TimePoints 
exacerbation in signs and symptoms  1 month 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   14/07/2019 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details
Modification(s)  
trial yet to be started 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary
Modification(s)  
Ayurveda, the most rational and scientific among the ancient systems of medicine, has immense potential to tackle many medical problems. Sushruta Samhita has described 76 Netrarogas, out of which 21 are Vartmagata Vikaras.Anjananamika is one of the Vartmagata, Raktpradhan and Shastrakritya (bhedan) sadhya vyadhi.The clinical features of Anjanamika resemble with an eye disease named as Hordeolum. It is an acute infection (usually Staphylococcal) involving either the glands of Zeis (External Hordeolum) or the Meibomian glands(Internal Hordeolum).Anjananamika is a raktaj vyadhi and for its intervention jalaukavcharana, vidalak and seka is selected as all three help in curing raktaj or rakta-pitta vitiated disorders. In this study, effort is made in the form of use of localised treatment with Jaluakavcharana and Yashtyadi lepa followed by Seka  and to find out a comparatively better alternate for Hordeolum among the both. The study will be intervened under 2 groups – group A ( Jalaukavcharana with Yashtyadi Seka and group B (Vidalaka with Yashtyadi lepa followed by Yashtyadi Seka) and duration of the trial will be of 5 days. The observation of patients will be carried out on day 1, on 3rd day and after completion of trial and after completion follow up will be done for 1 month

 
Close